Order Entry
Switzerland
ContactUsLinkComponent
Human recombinant VEGF R3 (from HEK293)
Human recombinant VEGF R3 (from HEK293)
Supplier:  ACROBIOSYSTEMS
Certificates
Human recombinant VEGF R3 (from HEK293)
Supplier:  ACROBIOSYSTEMS

Specifications

  • Conjugation:
    Unconjugated
  • Protein/peptide type:
    Recombinant
  • Source:
    HEK293 cells
  • Species:
    Human
  • Storage conditions:
    –20 °C
  • Endotoxin content:
    Less than 1,0 EU per μg by the LAL method.
  • Biological activity:
    Lyopilised from 0,22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH 7,5. Normally trehalose is added as protectant before lyophilisation.; Measured by its binding ability in a functional ELISA. Immobilised Human VEGF-C, His Tag at 5μg/ml (100 µl/well) can bind Human VEGF R3, Fc Tag with a linear range of 0,6-10 ng/ml (QC tested).; Measured by its binding ability in a functional ELISA. Immobilised Human VEGF R3, Fc Tag at 5μg/ml (100 µl/well) can bind Human VEGF-D, His Tag with a linear range of 0,08-0,6 μg/ml (Routinely tested).
  • Gene ID:
    P35916
  • Carrier-free:
    Y
  • Protease-free:
    Y
  • Animal-free:
    Y
  • Protein synonyms:
    Flt-4|VEGFR3|FLT4|LMPH1A|VEGFR-3|PCLFLT41|FLT-41|FLT41|FLT-4|PCL
  • Protein/peptide name:
    VEGF R3
  • Purity:
    >95%
  • Molecular weight:
    111,2 kDa
  • Endotoxin level:
    Low
  • Formulation:
    Lyopilised from 0,22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH 7,5. Normally trehalose is added as protectant before lyophilisation.
  • Nuclease-free:
    Y
  • Shipping temperature:
    Powder,RT

Specifications

Frequently Bought Together